Trevena TRVN August 2024 Investor Presentation

Trevena Inc. (NASDAQ: TRVN) presents its product pipeline strategy and clinical development initiatives as of August 2024. The presentation outlines the company's therapeutic candidates, commercial operations, and strategic alternatives for its marketed product OLINVYK, led by CEO Carrie L. Bourdow and the company's experienced leadership team.